MDMX phosphorylation-dependent p53 downregulation contributes to an immunosuppressive tumor microenvironment

Bing Wang1,2,3, Chuan-Bian Lim3, Jiawei Yan3

  • 1Key Laboratory of Space Radiobiology of Gansu Province & Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Sciences, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.

Insights

The tumor microenvironment (TME) plays a crucial role in cancer progression. This study reveals how targeting p53 in the TME can enhance anti-cancer therapy by restoring immune function.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • The tumor-suppressive role of p53 within the tumor microenvironment (TME) is understudied.
  • Understanding how tumors manipulate host p53 to create a pro-tumorigenic TME is critical.

Purpose of the Study:

  • To investigate how implanted tumor cells affect host p53 within the TME.
  • To explore the impact of p53 downregulation on immune cell activity and tumor progression.
  • To evaluate the therapeutic potential of modulating p53 activity in the TME.

Main Methods:

  • Utilized MdmxS314A mice as recipients for implanted tumor cells.
  • Analyzed p53 downregulation in peritumor cells induced by tumor cell-associated stress.
  • Assessed immune cell infiltration and macrophage polarization within the TME.
  • Investigated the effect of ablating MDMX-Ser314 phosphorylation on p53 levels and TME immunosuppression.

Main Results:

  • Tumor cells induced p53 downregulation in peritumor cells via MDMX-Ser314 phosphorylation.
  • This p53 decline resulted in an immunosuppressive TME with reduced immune cell infiltration and M1 macrophage polarization.
  • Ablating MDMX-Ser314 phosphorylation mitigated p53 decline, reduced immunosuppression, and delayed tumor growth.

Conclusions:

  • p53 plays a novel role in regulating the tumor immune microenvironment.
  • Restoring p53 activity within the TME presents a potential anticancer therapeutic strategy.
  • Targeting the MDMX-Ser314 phosphorylation pathway offers a means to modulate p53 and enhance anti-tumor immunity.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.8K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.9K